People with opioid use disorder (OUD) who have heart surgery suffer in-hospital mortality at a rate on par with other patients but are more likely to experience complications and require longer hospital stays, according to an analysis published in JAMA Surgery.

U.K.-based startup Cambridge Heartware has announced the launch of its company and its first product, a wearable heart monitor powered by artificial intelligence, in early 2019.

A U.S. District Court judge in Texas ruled on Dec. 14 the Affordable Care Act is unconstitutional, a decision that could throw the American healthcare system into turmoil.

VALHALLA, N.Y., Dec. 17, 2018 — Retia Medical, LLC, a medical device company focused on advancing the quality and clinical use of hemodynamic monitoring, today announced that its Argos Cardiac Output (CO) Monitor has received U.S. Food and Drug Administration 510k clearance and is now available for sale in the United States.

A recent analysis of last year’s FOURIER trial has found evolocumab, a PCSK9 inhibitor developed to treat hyperlipidemia, can robustly reduce low-density lipoprotein cholesterol (LDL-C) in patients without any major concern for individual-level variability in response.

Using coronary CT angiography to identify which patients with suspected coronary artery disease (CAD) really need invasive angiography can lower the overall cost of diagnostic testing without sacrificing safety, suggests a randomized trial published Dec. 12 in JACC: Cardiovascular Imaging.

Questioning older patients about their weight earlier in life could be a low-tech, low-cost way to better predict a person’s future risk of heart disease, according to a study published in the Journal of the American Heart Association.

A report issued Dec. 14 by the Campaign for Tobacco-Free Kids, American Heart Association and Truth Initiative, among other public health groups, ranked Alaska No. 1 in the nation for funding programs that protect high-school aged kids against tobacco use and help current smokers quit.

The implantable cardioverter defibrillator (ICD) market is projected to grow to $4.3 billion by 2028, with compound annual growth of 4.1 percent, according to a new report from GlobalData.

Women with atherosclerotic cardiovascular disease (ASCVD) were more likely to report worse experiences with the healthcare system and a lower health-related quality of life in a nationally representative study—highlighting another area where cardiovascular care potentially lags behind for women.